Engineered CAR-T cells show promise against glioblastoma in preclinical models Post author:admin Post published:November 20, 2025 Post category:uncategorized With a five-year survival rate of less than 5%, glioblastoma is one of the most aggressive types of brain cancer. You Might Also Like Tufts researchers explore the science of aging November 2, 2023 Oregon hospital races to build a tsunami shelter as FEMA fights to cut its funding December 17, 2025 Global increase in deaths from viral hepatitis revealed in WHO report April 10, 2024